Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $478.13 Million |
|---|---|
| Enterprise Value | $467.47 Million |
| Annual dividend | $1.98 |
| Dividend yield | 6.37% |
| Earnings per Share | $-0.91 |
| Beta | 1.14 |
| Outstanding Shares | 13,235,000 |
| P/E Ratio | 8.59 |
|---|---|
| PEG | 0.09 |
| Price to Sales | 2.62 |
| Price to Book Ratio | 0.56 |
| Enterprise Value to Revenue | 3.04 |
| Enterprise Value to EBIT | 3363.08 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong...
Stockcircle shows 16 open-market insider purchases for Chiron Real Estate in the last six months from SEC Form 4 reports by executives, directors, and other insiders.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.